Delivery Order SPE2DB20D3101-SPE2DB23FRVH6
Award Date
8/18/23
Potential Completion Date
8/21/23
Potential Value
$251
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $3,771.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. The single day order is for product delivery to a location in Conshohocken, Pennsylvania, with performance required on July 5-6, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense globally, this small order was placed under an existing DLA...
The Defense Logistics Agency awarded a $560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the order placed from August 21-22, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen will fulfill this small quantity order of a specialty drug to support the DLA's procurement programs...
The Defense Logistics Agency awarded a $754 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract starting September 5, 2023 and concluding September 6, 2023. The award was issued utilizing an unspecified government-wide acquisition contract vehicle. No set-aside designations or subcontractors were...
The Defense Logistics Agency awarded a $359,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania through August 2021. The award was made utilizing the Prime Vendor Program indefinite-delivery/indefinite-quantity contract vehicle. No set-aside provisions or subcontractors were identified. This supports the...
The Defense Logistics Agency awarded a $884.82 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 milligram/0.5 milliliter doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price arrangement concluding on September 25, 2023. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract, through which the agency obtains prescription drugs and other medical...
The Defense Logistics Agency awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 10-11, 2023. No subcontractors or set aside...
The Defense Logistics Agency awarded a $1,759.98 delivery order contract to Amerisourcebergen Drug Corporation for the purchase of 50mg/0.5ml doses of XYOSTED, an auto-injectable testosterone treatment. The contract has a firm fixed price and calls for delivery to a location in Conshohocken, Pennsylvania between August 18-21, 2023. No major subcontractors or set aside designations were identified. This order is likely in support of the DLA's medical supply chain responsibilities, to ensure...
The Defense Logistics Agency awarded a $276 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will take place in Conshohocken, Pennsylvania under a one-day period from July 6-7, 2023. The order was placed utilizing an existing DLA pharmaceuticals contract vehicle to supply this prescription product in support of DoD health programs. No set aside provisions or subcontractors...
The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy. The single order is for product delivery to a location in Conshohocken, Pennsylvania by July 19, 2023 to support the DLA's medical supply needs. Amerisourcebergen will perform as the prime contractor, drawing upon its extensive pharmaceutical distribution capabilities. The award is made...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $4,000 to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from August 4th through August 7th, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen...